Lycopene in Preventing Prostate Cancer in Healthy Participants

• Register: ClinicalTrials.gov
• Last refreshed on: 17 October 2012
• Main ID: NCT00322114
• Date of registration: 03/05/2006
• Primary sponsor: University of Illinois
• Public title: Lycopene in Preventing Prostate Cancer in Healthy Participants
• Scientific title: Mechanism of Prostate Cancer Prevention by Lycopene
• Date of first enrolment: February 2006
• Target sample size: 150
• Recruitment status: Recruiting
• URL: http://clinicaltrials.gov/show/NCT00322114
• Study type: Interventional
• Study design: Allocation: Randomized, Primary Purpose: Prevention

Countries of recruitment

United States

Contacts

• Name: Clinical Trial Office - University of Illinois Cancer Center

• Name: Richard B. van Breemen, PhD
• Affiliation: University of Illinois

Key inclusion & exclusion criteria

DISEASE CHARACTERISTICS:

- Healthy participants

- No existing prostate disease

PATIENT CHARACTERISTICS:

- Able to supply blood and urine samples

- Able to answer demographic and dietary recall questionnaires

- No hospital inpatients

- Not allergic to tomatoes or tomato products

- Not abusing alcohol or non-prescribed drugs

- No existing gastrointestinal disease or cancer

PRIOR CONCURRENT THERAPY:

- At least 2 weeks since prior lycopene (in supplement form)

- No concurrent participation in another clinical trial



Age minimum: 18 Years
Age maximum: N/A
Gender: Male

Health Condition(s) or Problem(s) studied

Prostate Cancer

Intervention(s)

Dietary Supplement: lycopene

Other: placebo

Primary Outcome(s)

Measurement of changes in percent free and total serum prostate-specific antigen (PSA) induced by lycopene [Time Frame: No]

Secondary ID(s)

CDR0000468031

UIC-2004-0217

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

National Cancer Institute (NCI)